Diagnostic Value of Artificial Intelligence-Based Pathology Diagnosis System in Lymphatic Metastasis of Gastric Cancer.
[INTRODUCTION] Gastric cancer (GC) remains one of the leading causes of cancer-related mortality worldwide, with lymph node metastasis (LNM) being an independent prognostic factor.
- 95% CI 0.84-0.94
- 연구 설계 meta-analysis
APA
Zhao T, Wu Q, et al. (2025). Diagnostic Value of Artificial Intelligence-Based Pathology Diagnosis System in Lymphatic Metastasis of Gastric Cancer.. Oncology, 103(9), 824-833. https://doi.org/10.1159/000542852
MLA
Zhao T, et al.. "Diagnostic Value of Artificial Intelligence-Based Pathology Diagnosis System in Lymphatic Metastasis of Gastric Cancer.." Oncology, vol. 103, no. 9, 2025, pp. 824-833.
PMID
39622222
Abstract
[INTRODUCTION] Gastric cancer (GC) remains one of the leading causes of cancer-related mortality worldwide, with lymph node metastasis (LNM) being an independent prognostic factor. However, there are still challenges in the pathological diagnosis of LNM in GC. The aim of this meta-analysis was to systematically evaluate the accuracy of artificial intelligence (AI) in detecting LNM in GC from whole-slide pathological images.
[METHODS] As of March 24, 2024, a comprehensive search for studies on the pathological diagnosis of GC LNM AI was performed in the databases of PubMed, Web of Science, Cochrane Library, and CNKI. Meta-analysis of the included data was performed using Meta-DiSc 1.4, Review Manager 5.4, and Stata SE 17.0 software to calculate diagnostic metrics such as overall sensitivity and specificity. The overall diagnostic performance of the AI was assessed. Meta-regression analysis explored sources of heterogeneity.
[RESULTS] A total of 7 articles involving 1,669 GC patients were included. The analysis showed that AI had a sensitivity of 0.90 (95% CI: 0.84-0.94) and a specificity of 0.95 (95% CI: 0.91-0.98) for the diagnosis of GC LNM, with significant heterogeneity across studies. The area under the curve was 0.97, indicating an excellent diagnostic value. Meta-regression analysis showed that the sample size and the number of study centers contributed to the heterogeneity.
[CONCLUSION] AI for diagnosing LNM in GC from whole-slide pathological images demonstrates high accuracy, offering significant clinical implications for improving diagnosis and treatment strategies.
[METHODS] As of March 24, 2024, a comprehensive search for studies on the pathological diagnosis of GC LNM AI was performed in the databases of PubMed, Web of Science, Cochrane Library, and CNKI. Meta-analysis of the included data was performed using Meta-DiSc 1.4, Review Manager 5.4, and Stata SE 17.0 software to calculate diagnostic metrics such as overall sensitivity and specificity. The overall diagnostic performance of the AI was assessed. Meta-regression analysis explored sources of heterogeneity.
[RESULTS] A total of 7 articles involving 1,669 GC patients were included. The analysis showed that AI had a sensitivity of 0.90 (95% CI: 0.84-0.94) and a specificity of 0.95 (95% CI: 0.91-0.98) for the diagnosis of GC LNM, with significant heterogeneity across studies. The area under the curve was 0.97, indicating an excellent diagnostic value. Meta-regression analysis showed that the sample size and the number of study centers contributed to the heterogeneity.
[CONCLUSION] AI for diagnosing LNM in GC from whole-slide pathological images demonstrates high accuracy, offering significant clinical implications for improving diagnosis and treatment strategies.
MeSH Terms
Humans; Artificial Intelligence; Lymphatic Metastasis; Sensitivity and Specificity; Stomach Neoplasms
같은 제1저자의 인용 많은 논문 (5)
- Chrysophanol attenuates breast cancer angiogenesis through blocking VEGFA/VEGFR2/ERK activation via inhibiting ACE2 ubiquitination.
- Ultrasound and ROS-responsive nanodroplets inhibit TCA cycle in hepatocellular carcinoma.
- Retraction notice to "Roles of long non-coding RNA in prostate cancer pathogenesis" [Clinical Genitourinary Cancer 22 (2024) 102213].
- Diagnostic Pitfalls of -Rearranged Perivascular Epithelioid Cell Tumor of the Kidney.
- Diagnostic Challenges in Identifying Concurrent Myeloid Sarcoma and High-Grade Prostatic Adenocarcinoma Within the Prostate.